Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Apr-30-22 | Apr-24-21 | Apr-25-20 | Apr-27-19 | Apr-28-18 | Apr-29-17 | Apr-30-16 | Apr-25-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Animal Health net sales | 3,982.9 | 3,560.0 | 3,336.3 | 3,354.5 | 3,242.6 | 3,159.8 | | |
Dental net sales | 2,516.1 | 2,327.0 | 2,101.9 | 2,191.8 | 2,196.1 | 2,390.2 | | |
Corporate net sales | 0.4 | 25.1 | 51.8 | 28.2 | 27.0 | 43.1 | | |
Total revenues [+] | 6,499.4 | 5,912.1 | 5,490.0 | 5,574.5 | 5,465.7 | 5,593.1 | 5,386.7 | 3,910.9 |
Products | 6,499.4 | 5,912.1 | 5,490.0 | 5,574.5 | 5,465.7 | 5,593.1 | | |
Revenue growth [+] | 9.9% | 7.7% | -1.5% | 2.0% | -2.3% | 3.8% | 37.7% | 9.1% |
Animal Health net sales | 11.9% | 6.7% | -0.5% | 3.5% | 2.6% | | | |
Dental net sales | 8.1% | 10.7% | -4.1% | -0.2% | -8.1% | | | |
Corporate net sales | -98.4% | -51.7% | 83.8% | 4.3% | -37.2% | | | |
Animal Health | | | | | | | 96.5% | 21.1% |
Cost of goods sold | 5,210.3 | 4,708.9 | 4,292.6 | 4,383.7 | 4,266.3 | 4,291.7 | 4,064.0 | 2,850.3 |
Gross profit | 1,289.1 | 1,203.1 | 1,197.4 | 1,190.8 | 1,199.4 | 1,301.4 | 1,322.7 | 1,060.5 |
Gross margin | 19.8% | 20.4% | 21.8% | 21.4% | 21.9% | 23.3% | 24.6% | 27.1% |
Selling, general and administrative | 1,132.1 | 992.5 | 675.1 | 1,053.1 | 979.5 | 1,013.5 | 975.0 | 756.0 |
Other operating expenses | | | 419.4 | | | | | |
EBITDA [+] | 239.0 | 289.5 | 185.1 | 220.5 | 303.7 | 371.7 | 430.1 | 349.1 |
EBITDA growth | -17.4% | 56.4% | -16.0% | -27.4% | -18.3% | -13.6% | 23.2% | 3.8% |
EBITDA margin | 3.7% | 4.9% | 3.4% | 4.0% | 5.6% | 6.6% | 8.0% | 8.9% |
Depreciation | 44.2 | 41.7 | 45.0 | 44.4 | 45.1 | 40.0 | 34.3 | 23.8 |
EBITA | 194.8 | 247.8 | 140.1 | 176.1 | 258.6 | 331.7 | 395.8 | 325.3 |
EBITA margin | 3.0% | 4.2% | 2.6% | 3.2% | 4.7% | 5.9% | 7.3% | 8.3% |
Amortization of intangibles | 37.8 | 37.2 | 37.2 | 38.4 | 38.7 | 43.8 | 48.1 | 20.8 |
EBIT [+] | 157.0 | 210.6 | 102.9 | 137.7 | 219.9 | 287.9 | 347.7 | 304.6 |
EBIT growth | -25.5% | 104.6% | -25.3% | -37.4% | -23.6% | -17.2% | 14.2% | 3.7% |
EBIT margin | 2.4% | 3.6% | 1.9% | 2.5% | 4.0% | 5.1% | 6.5% | 7.8% |
Non-recurring items | | | 675.1 | | | | | |
Interest expense | 20.3 | 24.3 | 41.8 | 39.7 | 46.7 | 43.1 | 50.1 | 33.7 |
Interest expense | 20.3 | 24.3 | 41.8 | 39.7 | 46.7 | 43.1 | 50.1 | 33.7 |
Other income (expense), net [+] | 129.5 | 13.6 | 23.5 | 8.2 | 6.1 | 6.0 | 4.0 | 3.4 |
Other | 27.7 | 13.6 | -10.8 | 8.2 | 6.1 | 6.0 | 4.0 | 3.4 |
Pre-tax income | 266.3 | 199.9 | -590.4 | 106.2 | 179.3 | 250.9 | 301.7 | 274.3 |
Income taxes | 64.5 | 44.8 | -1.0 | 23.4 | -21.7 | 77.1 | 116.0 | 94.2 |
Tax rate | 24.2% | 22.4% | 0.2% | 22.0% | | 30.7% | 38.5% | 34.4% |
Minority interest | -1.5 | -0.9 | -0.9 | -0.8 | | | | |
Earnings from continuing ops | 203.2 | 156.0 | -588.4 | 83.6 | 201.0 | 173.8 | 185.7 | 180.1 |
Earnings from discontinued ops | | | | | | -2.9 | 1.5 | 43.2 |
Net income | 203.2 | 156.0 | -588.4 | 83.6 | 201.0 | 170.9 | 187.2 | 223.3 |
Net margin | 3.1% | 2.6% | -10.7% | 1.5% | 3.7% | 3.1% | 3.5% | 5.7% |
|
Basic EPS [+] | $2.09 | $1.63 | ($6.25) | $0.90 | $2.17 | $1.83 | $1.91 | $1.82 |
Growth | 28.0% | -126.1% | -793.2% | -58.5% | 18.7% | -4.1% | 5.0% | 7.0% |
Diluted EPS [+] | $2.06 | $1.61 | ($6.25) | $0.89 | $2.16 | $1.82 | $1.90 | $1.81 |
Growth | 27.8% | -125.8% | -798.6% | -58.6% | 18.7% | -4.1% | 5.0% | 7.2% |
|
Dividends per share [+] | $1.04 | $1.04 | $1.04 | $1.04 | $1.04 | $0.98 | $0.90 | $0.82 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 6.1% | 8.9% | 9.8% | 20.6% |
|
Shares outstanding (basic) [+] | 97.3 | 95.6 | 94.2 | 92.8 | 92.5 | 94.9 | 97.2 | 99.0 |
Growth | 1.8% | 1.5% | 1.5% | 0.3% | -2.6% | -2.4% | -1.8% | -1.7% |
Shares outstanding (diluted) [+] | 98.5 | 96.7 | 94.2 | 93.5 | 93.1 | 95.6 | 97.9 | 99.7 |
Growth | 1.9% | 2.7% | 0.7% | 0.4% | -2.6% | -2.4% | -1.8% | -1.9% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|